Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study

V. Koblizek, B. Milenkovic, A. Barczyk, R. Tkacova, A. Somfay, K. Zykov, N. Tudoric, K. Kostov, Z. Zbozinkova, J. Svancara, J. Sorli, A. Krams, M. Miravitlles, A. Valipour,

. 2017 ; 49 (5) : . [pub] 20170511

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010576

Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region.Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) study was offered to stable patients with COPD in a real-life setting. The primary aim of this study was to assess the prevalence of phenotypes according to predefined criteria. Secondary aims included analysis of differences in symptom load, comorbidities and pharmacological treatment.3362 patients with COPD were recruited in 10 CEE countries. 63% of the population were nonexacerbators, 20.4% frequent exacerbators with chronic bronchitis, 9.5% frequent exacerbators without chronic bronchitis and 6.9% were classified as asthma-COPD overlap. Differences in the distribution of phenotypes between countries were observed, with the highest heterogeneity observed in the nonexacerbator cohort and the lowest heterogeneity observed in the asthma-COPD cohort. There were statistically significant differences in symptom load, lung function, comorbidities and treatment between these phenotypes.The majority of patients with stable COPD in CEE are nonexacerbators; however, there are distinct differences in surrogates of disease severity and therapy between predefined COPD phenotypes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010576
003      
CZ-PrNML
005      
20180417111337.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1183/13993003.01446-2016 $2 doi
035    __
$a (PubMed)28495687
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Koblizek, Vladimir $u Dept of Pneumology, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic.
245    10
$a Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study / $c V. Koblizek, B. Milenkovic, A. Barczyk, R. Tkacova, A. Somfay, K. Zykov, N. Tudoric, K. Kostov, Z. Zbozinkova, J. Svancara, J. Sorli, A. Krams, M. Miravitlles, A. Valipour,
520    9_
$a Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region.Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) study was offered to stable patients with COPD in a real-life setting. The primary aim of this study was to assess the prevalence of phenotypes according to predefined criteria. Secondary aims included analysis of differences in symptom load, comorbidities and pharmacological treatment.3362 patients with COPD were recruited in 10 CEE countries. 63% of the population were nonexacerbators, 20.4% frequent exacerbators with chronic bronchitis, 9.5% frequent exacerbators without chronic bronchitis and 6.9% were classified as asthma-COPD overlap. Differences in the distribution of phenotypes between countries were observed, with the highest heterogeneity observed in the nonexacerbator cohort and the lowest heterogeneity observed in the asthma-COPD cohort. There were statistically significant differences in symptom load, lung function, comorbidities and treatment between these phenotypes.The majority of patients with stable COPD in CEE are nonexacerbators; however, there are distinct differences in surrogates of disease severity and therapy between predefined COPD phenotypes.
650    _2
$a senioři $7 D000368
650    _2
$a bronchitida $x komplikace $x diagnóza $7 D001991
650    _2
$a chronická bronchitida $x komplikace $7 D029481
650    _2
$a komorbidita $7 D015897
650    _2
$a průřezové studie $7 D003430
650    _2
$a sběr dat $7 D003625
650    _2
$a Evropa $x epidemiologie $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a usilovný výdechový objem $7 D005541
650    _2
$a lidé $7 D006801
650    _2
$a mezinárodní spolupráce $7 D007391
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a fenotyp $7 D010641
650    _2
$a prevalence $7 D015995
650    _2
$a chronická obstrukční plicní nemoc $x komplikace $x diagnóza $x patofyziologie $7 D029424
650    _2
$a kouření $x epidemiologie $7 D012907
650    _2
$a poruchy vyvolané užíváním tabáku $x komplikace $x diagnóza $7 D014029
650    _2
$a výsledek terapie $7 D016896
650    _2
$a vitální kapacita $7 D014797
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Milenkovic, Branislava $u Clinic for Pulmonary Diseases, Faculty of Medicine, Clinical Centre of Serbia, Belgrade, Serbia.
700    1_
$a Barczyk, Adam $u Dept of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
700    1_
$a Tkacova, Ruzena $u Dept of Respiratory Medicine and Tuberculosis, Faculty of Medicine, P.J. Safarik University, Kosice, Slovakia.
700    1_
$a Somfay, Attila $u Dept of Pulmonology, University of Szeged, Deszk, Hungary.
700    1_
$a Zykov, Kirill $u Laboratory of Pulmonology, Moscow State University of Medicine and Dentistry named after A.I.Evdokimov, Moscow, Russia.
700    1_
$a Tudoric, Neven $u School of Medicine Zagreb, University Hospital Dubrava, Zagreb, Croatia.
700    1_
$a Kostov, Kosta $u Clinic of Pulmonary Diseases, Military Medical Academy, Sofia, Bulgaria.
700    1_
$a Zbozinkova, Zuzana $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Svancara, Jan $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Sorli, Jurij $u Pulmonary Dept, Topolsica Hospital, Topolsica, Slovenia.
700    1_
$a Krams, Alvils $u Faculty of Medicine, University of Latvia, Riga, Latvia.
700    1_
$a Miravitlles, Marc $u Pneumology Dept, Hospital Universitari Vall d'Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
700    1_
$a Valipour, Arschang $u Dept of Respiratory and Critical Care Medicine, Ludwig-Boltzmann-Institute for COPD and Respiratory Epidemiology, Otto-Wagner-Spital, Vienna, Austria arschang.valipour@wienkav.at.
773    0_
$w MED00001660 $t The European respiratory journal $x 1399-3003 $g Roč. 49, č. 5 (2017)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28495687 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180417111436 $b ABA008
999    __
$a ok $b bmc $g 1288061 $s 1007388
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 49 $c 5 $e 20170511 $i 1399-3003 $m The European respiratory journal $n Eur Respir J $x MED00001660
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Možnosti archivace